LinkPeptide
![[Thr28, Nle31]-Cholecystokinin (25-33), sulfate...](https://www.linkpeptide.com/wp-content/uploads/2026/06/Thr28-Nle31-Cholecystokinin-25-33-sulfated-CCK-9.jpg "[Thr28, Nle31]-Cholecystokinin (25-33), sulfate...")
![[Phe2,Nle4] ACTH (1-24), human](https://www.linkpeptide.com/wp-content/uploads/2025/04/Phe2Nle4-ACTH-1-24-human.webp "[Phe2,Nle4] ACTH (1-24), human")
![[Arg6]-beta-Amyloid (1-40), England Mutation](https://www.linkpeptide.com/wp-content/uploads/2026/06/Arg6-beta-Amyloid-1-40-England-Mutation.jpg "[Arg6]-beta-Amyloid (1-40), England Mutation")
![[pThr11]-Histone H3 (1-21)-GGK(Biotin)-NH2](https://www.linkpeptide.com/wp-content/uploads/2026/06/pThr11-Histone-H3-1-21-GGKBiotin-NH2.jpg "[pThr11]-Histone H3 (1-21)-GGK(Biotin)-NH2")
Get a Quote
Get a Quote
LinkPeptide provides high quality catalog peptides with different purity at highly competitive prices. Our catalog peptides are supported by our unparalleled experience in peptide synthesis. We have nearly 10 years experience in synthesizing peptides, LinkPeptide is the premier supplier of high quality peptides to leading biotechnology companies and academic institutions.
8
years of trusted peptide supply
Providing high-quality bioactive peptides, inhibitors, and custom peptide synthesis for pharmaceutical and academic research.
High-quality peptides for research, drug discovery, and cosmetic applications, 8+ years of peptide synthesis expertise,
End-to-end solutions from custom synthesis to large-scale production, flexible support for diverse research needs
8+ years of peptide synthesis expertise: Where proven quality meets advanced technologies for modern life science research.
LinkPeptide delivers high-quality catalog peptides with multiple purity options at competitive prices. Our products are backed by extensive experience in peptide synthesis and strict quality control standards.
With nearly a decade of expertise, LinkPeptide is a trusted partner for biotechnology companies and academic institutions, supporting research in drug discovery, molecular biology, and cosmetic science.
LinkPeptide provides high quality catalog peptides with different purity at highly competitive prices. Our catalog peptides are supported by our unparalleled experience in peptide synthesis. We have nearly 10 years experience in synthesizing peptides, LinkPeptide is the premier supplier of high quality peptides to leading biotechnology companies and academic institutions.
State-of-the-art production site supporting scalable peptide synthesis, from research-grade batches to large-scale manufacturing.
SPPS Synthesis Laboratory Equipped with advanced solid-phase peptide synthesis (SPPS) platforms, enabling precise, efficient, and high-throughput peptide productio
SPPS Synthesis Laboratory
Equipped with advanced solid-phase peptide synthesis (SPPS) platforms, enabling precise, efficient, and high-throughput peptide production.
Integrated Production Workflow
Seamless transition from synthesis to purification and analysis, ensuring fast turnaround and reproducible, high-quality peptide products.
HPLC & Mass Spectrometry
High-performance liquid chromatography (HPLC) and MS systems for purity analysis, identity confirmation, and batch consistency verification.
Peptide–drug conjugates (PDCs) are emerging as a flexible platform for targeted drug delivery in hematological malignancies. A typical PDC combines a targeting or cell-penetrating peptide with a linker and a pharmacologically active payload. This modular architecture allows researchers to optimize target recognition, intracellular transport, ci…
Details
The global skincare market is entering a new era defined by scientific innovation and consumer demand for efficacy. Among the most promising breakthroughs are peptides, biomimetic molecules that deliver regenerative benefits by stimulating collagen, repairing the skin barrier, and supporting a balanced microbiome. Unlike traditional actives, pe…
Motixafortide is a selective CXCR4 antagonist that has recently gained FDA approval for its use in combination with G-CSF to mobilize hematopoietic stem cells (HSCs) in patients with multiple myeloma. This novel agent disrupts the CXCL12/CXCR4 axis, promoting the release of HSCs from the bone marrow into peripheral blood, facilitating autologou…
AbstractAs the demand for peptide-based therapeutics grows, so too does the need for sustainable manufacturing methods. Traditional solid-phase peptide synthesis (SPPS), typically performed in the C-to-N direction, has long dominated the field—but it comes at a high environmental cost, consuming large amounts of reagents, solvents, and energy. …